Healthcare provider profile · identity verified

Daniel Charles Wallace, M.D.

Family Practice · CAMBRIDGE, MN · NPI 1083848063

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	326	101
Omeprazole	Omeprazole	290	92
Losartan Potassium	Losartan Potassium	255	72
Amlodipine Besylate	Amlodipine Besylate	247	76
Metoprolol Succinate	Metoprolol Succinate	213	64
Lovastatin	Lovastatin	205	60
Lisinopril	Lisinopril	197	58
Metformin Hcl Er	Metformin Hcl	183	59
Gabapentin	Gabapentin	180	57
Levothyroxine Sodium	Levothyroxine Sodium	165	44
Tizanidine Hcl	Tizanidine Hcl	160	53
Famotidine	Famotidine	153	59
Tamsulosin Hcl	Tamsulosin Hcl	145	44
Hydrochlorothiazide	Hydrochlorothiazide	136	40
Fluticasone Propionate	Fluticasone Propionate	128	73
Furosemide	Furosemide	120	39
Trazodone Hcl	Trazodone Hcl	116	39
Allopurinol	Allopurinol	109	30
Doxazosin Mesylate	Doxazosin Mesylate	103	27
Atenolol	Atenolol	91	26
Metoprolol Tartrate	Metoprolol Tartrate	91	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	22
Albuterol Sulfate Hfa	Albuterol Sulfate	88	44
Finasteride	Finasteride	88	26
Jardiance	Empagliflozin	86	25
Eliquis	Apixaban	85	23
Rosuvastatin Calcium	Rosuvastatin Calcium	82	28
Warfarin Sodium	Warfarin Sodium	78	21
Clopidogrel	Clopidogrel Bisulfate	72	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	21
Simvastatin	Simvastatin	67	19
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	64	11
Escitalopram Oxalate	Escitalopram Oxalate	63	19
Sertraline Hcl	Sertraline Hcl	63	22
Glipizide Er	Glipizide	60	19
Triamcinolone Acetonide	Triamcinolone Acetonide	60	32
Nitroglycerin	Nitroglycerin	58	41
Potassium Chloride	Potassium Chloride	54	20
Pantoprazole Sodium	Pantoprazole Sodium	53	19
Montelukast Sodium	Montelukast Sodium	52	19
Pravastatin Sodium	Pravastatin Sodium	52	15
Metformin Hcl	Metformin Hcl	51	15
Carvedilol	Carvedilol	45	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	12
Oxycodone Hcl	Oxycodone Hcl	42	15
Ozempic	Semaglutide	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	11
Pregabalin	Pregabalin	39	14
Spironolactone	Spironolactone	39	11
Duloxetine Hcl	Duloxetine Hcl	38	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	12
Propranolol Hcl	Propranolol Hcl	35	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	11
Prednisone	Prednisone	32	24
Ventolin Hfa	Albuterol Sulfate	30	18
Lansoprazole	Lansoprazole	28	suppressed
Clonazepam	Clonazepam	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	21
Lorazepam	Lorazepam	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	13
Nifedipine Er	Nifedipine	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Alprazolam	Alprazolam	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Latanoprost	Latanoprost	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Glipizide	Glipizide	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Prevalite	Cholestyramine	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error